Martin Spoerk, · Ioannis Koutsamanis, · Andreas Kottlan, · Christian Makert, Michael Piller, Manuel Rajkovaca, · Amrit Paudel, · Johannes Khinast
https://doi.org/10.1208/s12249-022-02405-7
A novel, solvent-free, continuous hot-melt extrusion-based approach with an inline cold pelletization step and the potential of unprecedented on-the-fly formulation changes, aiming at producing the smallest microparticulate drug delivery systems particles usable for injectable applications. A biodegradable, crystalline dispersion consisting of poly(DL-lactic acid) (PLA) filled with metformin was chosen to elucidate the broad applicability of the process also to formulations with limited stretchability and complex pelletizability.
Fast extrudate haul-off speeds and high numbers of pelletizer knives resulted in particles with a narrow and small particle size distribution with a d50 below 270 µm and aspect ratios close to 1. Upon adapting the syringe diameter, the produced micropellets revealed similar injectability parameters to the marketed formulation.







